Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
Compositions and methods are disclosed for stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more of these uses. Disorders that can be diagnosed, prevented, or treated by the compositions herein include trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy. In addition, the present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cell comprising those nucleic acid sequences, chimerie polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Genentech, Inc.
A A G A G C A A A A G A A A A A A G G A G
A61P A61P G01N A61P G01N C07K A61P A61P A61P A61P G01N A61K A61P A61P A61P A61P A61P G01N G01N A61P G01N
inventional inventional additional inventional inventional inventional inventional inventional inventional inventional additional additional inventional inventional inventional inventional inventional inventional inventional inventional additional
Daniel K. William I. Austin L.
Kirchhofer Wood Gurney